Open Government Canada
Guidance for market authorization requirements for COVID-19 drugs: Overview
Published by Health Canada | Santé Canada
About this dataset
This document provides guidance to drug manufacturers seeking authorization for their drug manufactured, sold, or represented for use in relation to COVID-19. The guidance explains recent changes to the regulatory process for new COVID-19 drugs.